Related by context. All words. (Click for frequent words.) 76 5 FU leucovorin 74 FOLFOX6 chemotherapy regimen 74 Folfox 73 Xelox 73 capecitabine Xeloda 73 trastuzumab Herceptin R 72 evaluating tivozanib 72 docetaxel Taxotere R 72 oral chemotherapeutic agent 72 FUSILEV enhances 72 5 fluorouracil leucovorin 72 gemcitabine chemotherapy 72 cisplatin gemcitabine 71 5 Fluorouracil 71 paclitaxel Taxol ® 71 Hormone Refractory Prostate Cancer 71 pegylated liposomal doxorubicin 71 pertuzumab 71 cyclophosphamide doxorubicin vincristine 71 alfa 2a 70 cyclophosphamide methotrexate 70 standard chemotherapy regimen 70 evaluating satraplatin 70 bevacizumab Avastin R 70 sorafenib Nexavar ® 70 gemcitabine Gemzar 70 prednisone CHOP 70 irinotecan doxorubicin oxaliplatin paclitaxel 70 interferon gamma 1b 70 Xeloda ® 70 Pertuzumab 70 infliximab monotherapy 70 humanized therapeutic 70 Adjuvant Treatment 70 Randomized Phase 70 sorafenib tablets 70 Camptosar ® 69 Aflibercept 69 MGd 69 Camptosar ® irinotecan 69 sorafenib Nexavar 69 Alkeran 69 docetaxel chemotherapy 69 ritonavir boosted 69 AAG geldanamycin analog 69 Ixempra 69 Intravitreal 69 plus dexamethasone 69 erlotinib Tarceva ® 69 bortezomib Velcade R 69 FOLFOX6 69 dasatinib Sprycel 69 bevacizumab Avastin ® 69 Pegasys peginterferon alfa 2a 69 Peginterferon alfa 2b 69 TO AVOID PREGNANCY WHILE 69 evaluating picoplatin 69 Copegus ribavirin 69 Sandostatin R 69 Irinotecan 69 estramustine 69 Platinol ® cisplatin 68 HGS ETR1 mapatumumab 68 folinic acid 68 daunorubicin 68 Peginterferon 68 oral levofloxacin 68 galiximab 68 Xeloda capecitabine 68 oxaliplatin Eloxatin 68 azilsartan medoxomil 68 refractory chronic lymphocytic 68 Gemcitabine 68 ChronVac C R 68 monoclonal antibody IgG1 Mab 68 Panzem NCD 68 Mg Usa 68 cetuximab Erbitux R 68 sorafenib Nexavar R 68 CYP#A# CYP#D# 68 Medoxomil 68 Panzem R NCD 68 Azacitidine 68 Vidaza ® 68 HGS# 68 thalidomide Thalomid 68 CYT# potent vascular disrupting 68 relapsed MM 67 Naive Patients 67 FOLFIRI 67 SPRYCEL ® 67 vapreotide acetate 67 infusional 5-FU/LV 67 docetaxel Taxotere 67 evaluating T DM1 67 pregabalin Lyrica 67 Oral Fingolimod 67 nucleoside analog 67 Flu Cy 67 INSPIRE Trial Phase III 67 cisplatin vinorelbine 67 Meets Primary Endpoint 67 Herceptin trastuzumab 67 vincristine doxorubicin 67 cediranib 67 tenofovir emtricitabine 67 progressive metastatic prostate 67 pegylated interferon alpha 67 Hsp# Inhibitor 67 Pivotal Phase 67 sunitinib malate 67 liposomal formulation 67 cyclophosphamide chemotherapy 67 pan histone deacetylase 67 nilotinib Tasigna 67 recurrent metastatic ovarian cancer 67 Mg Uk 67 8mg/kg 67 Antitumor Activity 67 Doxil ® 67 interferon alfa 2a 67 Elotuzumab 67 targeted antifolate 67 gemcitabine carboplatin 67 erlotinib Tarceva R 67 Pegylated Liposomal Doxorubicin 67 docetaxel Taxotere ® 67 EndoTAGTM 1 67 YONDELIS 67 XELOX 67 metastatic colorectal carcinoma 67 Glufosfamide 67 ZOLINZA 67 Tykerb lapatinib 67 anti angiogenic agent 67 Imprime PGG 67 3mg/kg 67 Temsirolimus 67 chemotherapy cisplatin 67 biologic antibody 67 PEGylated Fab fragment 67 metaglidasen 67 Taxotere chemotherapy 67 paclitaxel Taxol R 67 Peg IFN 67 PEGylated anti 67 vorinostat 67 VANTAS ® 67 HCV NS5B polymerase 67 Complicated Skin 67 IMiDs ® 67 Angiotensin Converting Enzyme 67 Taxotere docetaxel 67 plus dacarbazine 67 carboplatin paclitaxel 67 Kinase Inhibitor 66 Phase 2b Clinical Trial 66 lenalidomide Revlimid R 66 Platinol ® 66 ® lenalidomide 66 vinorelbine tartrate 66 PSMA ADC 66 5-FU/LV 66 sulfonylurea glimepiride 66 Paraplatin ® 66 aspirin clopidogrel 66 Bezielle 66 Epirubicin 66 corticosteroid dexamethasone 66 Gemzar gemcitabine 66 FOLFIRI chemotherapy 66 pharmacologically active isomer 66 radiation chemoradiation 66 Vandetanib 66 ADP receptor antagonist 66 liposome encapsulated 66 Melphalan 66 Erbitux cetuximab 66 Parathyroid Hormone 66 FOLFOX 66 Pharmacokinetics PK 66 Pemetrexed 66 oral rivaroxaban 66 Neulasta ® 66 bevacizumab Avastin 66 PKC# 66 Completes Patient Enrollment 66 TNF Tumor Necrosis Factor 66 Pfizer Camptosar 66 Initiates Enrollment 66 humanised monoclonal antibody 66 metastatic hormone refractory 66 virus HCV protease inhibitor 66 doxorubicin cyclophosphamide 66 R sorafenib tablets 66 Bayer HealthCare Onyx Pharmaceuticals 66 BRAF inhibitor 66 Fludara ® 66 Cetuximab Erbitux 66 See CLINICAL PHARMACOLOGY 66 evaluating Actimmune 66 brand ciclesonide HFA 66 prednisone prednisolone plus 66 AKT inhibitor 66 teriflunomide 66 paclitaxel chemotherapy 66 Sapacitabine 66 telaprevir dosed 66 Patients Treated With 66 Temodar ® 66 AEGR 66 Rigel R# 66 gp# vaccine 66 somatostatin analog 66 daily Infergen 66 non nucleoside inhibitor 66 Tarceva TM 66 ACTEMRA TM 66 ATRA IV 66 Novel Oral 66 IMiDs ® compound 66 ritonavir boosted atazanavir 66 OSI Tarceva 66 demonstrated antitumor activity 66 Aliskiren 66 Taxotere ® 66 OMP #R# 66 chemotherapeutic agents carboplatin 66 TTF Therapy 66 Bevacizumab Avastin 66 dexamethasone Decadron 66 Interferon alfa 66 Fludarabine 66 Pegasys ® 66 FOLFOX4 66 mapatumumab 66 AN# topical anti 66 novel VDA molecule 66 ACE inhibitor benazepril 66 GW# [003] 66 Gemzar ® 66 biologic DMARD 66 DexaSite 66 Fulvestrant 66 pegylated interferon alfa 2a 66 AVASTIN 66 selective estrogen receptor modulator 66 cortisol synthesis 66 R lenalidomide 66 developing Bicifadine serotonin 66 PI3K/Akt pathway inhibitor 66 metformin sulfonylurea 66 Pegylated Interferon 66 adalimumab Humira 66 metastatic castration resistant 66 plus prednisone prednisolone 66 candesartan cilexetil 65 sunitinib Sutent 65 mitoxantrone plus 65 Annamycin 65 Bevacizumab 65 potent CYP#A# inhibitors 65 liposomal doxorubicin 65 gemcitabine cisplatin 65 dasatinib Sprycel ® 65 ErbB2 positive 65 Hycamtin ® 65 oral prodrug 65 cytarabine daunorubicin 65 HER2 ErbB2 65 assessing T DM1 65 Capecitabine 65 Decitabine 65 ixabepilone 65 lenalidomide Revlimid ® 65 Campath alemtuzumab 65 epirubicin cyclophosphamide 65 azacytidine 65 vinca alkaloid 65 #mg ritonavir 65 Initiate Clinical Trial 65 HER2 Positive 65 Liposomal 65 plus prednisone 65 novel histone deacetylase 65 Study Evaluating 65 2 methoxyestradiol 65 agonistic human 65 stage IIIb IV 65 Investigational Oral 65 MAGE A3 ASCI 65 iniparib 65 pan HDAC inhibitor 65 maximally tolerated dose 65 temozolomide TMZ 65 Romiplostim 65 Carboplatin 65 Degarelix 65 Velcade bortezomib 65 adriamycin 65 ribavirin RBV 65 PF # [002] 65 Prolongs Survival 65 Interferon beta 1a 65 Presents Preclinical Data 65 sargramostim 65 boosted protease inhibitor 65 Zorbtive TM 65 orally administered inhibitor 65 ZACTIMA 65 lintuzumab SGN 65 Boceprevir 65 HER2 positive metastatic breast 65 EOquin TM phase 65 Fluorouracil 65 5FU 65 Bosutinib 65 Initiate Phase 65 Lenalidomide 65 Taxol paclitaxel 65 midstage clinical 65 valsartan amlodipine 65 Demonstrates Significant 65 Prednisone Against Refractory 65 alendronate Fosamax 65 exemestane Aromasin 65 Sustiva efavirenz 65 myelodysplastic myeloproliferative diseases 65 carboplatin chemotherapy 65 pegylated interferon alpha 2a 65 tumor activated prodrug 65 paclitaxel Taxol 65 inflammatory PDE 65 letrozole Femara 65 non resectable 65 melphalan prednisone 65 GlaxoSmithKline Tykerb 65 Initiates Phase II 65 paclitaxel poliglumex 65 plus fludarabine 65 PRN FDA Approves 65 Natalizumab 65 Cyclophosphamide 65 NS5B polymerase 65 acyclovir Lauriad R 65 Crofelemer budesonide foam 65 Trastuzumab DM1 65 Autologous Stem Cell Transplantation 65 neratinib 65 fluorouracil 65 PEGINTRON TM 65 irbesartan 65 Neoadjuvant 65 CIMZIA ™ 65 ® bortezomib 65 intravesical infusion therapy 65 DNA methyltransferase inhibitors 65 FEMALES SHOULD BE ADVISED 65 Pegasys R 65 nicardipine 65 TAXOTERE R 65 By JENNIFER LEARN 65 abacavir lamivudine 65 GVAX ® 65 plus Copegus R 65 Talabostat 65 Presents Preclinical 65 COPEGUS R 65 Oxaliplatin 65 xenograft models 65 KRN# 65 OMP #M# 65 oral clodronate 65 angiogenesis inhibitor 65 IMiDs R 64 topical gel formulation 64 denileukin diftitox 64 accumulate preferentially 64 Etoposide 64 Pegintron 64 alpha 2a 64 CIMZIA TM 64 kidney urologic 64 Single Dose 64 AZT zidovudine Retrovir 64 octreotide acetate 64 selective orally bioavailable 64 novel emulsion formulation 64 BRIM2 64 goserelin 64 Phase Ib II 64 beta 1a 64 TLK# 64 tyrosine kinase inhibitor TKI 64 Cardiotoxicity 64 Bicalutamide 64 pegylated interferon peg IFN 64 Nilotinib 64 antibody MAb 64 Nexavar sorafenib 64 Novartis Femara 64 Initiates Phase III 64 Trastuzumab 64 ELOXATIN 64 Xcytrin R 64 Dapagliflozin 64 epirubicin 64 Launches Generic Version 64 nab paclitaxel 64 tiotropium bromide 64 Polymerase Inhibitor 64 CYP#A# substrate 64 Paraplatin ® carboplatin 64 Aptivus ® 64 approved incretin mimetic 64 Neupogen ® 64 acetonide FA 64 Ixabepilone 64 Panitumumab 64 R Saizen R 64 Vitrasert R 64 Tumor Response 64 Treatment Naive Patients 64 Pazopanib 64 folinic acid FA 64 Ibritumomab Tiuxetan 64 Treatment Naïve 64 mertansine 64 bortezomib Velcade 64 zoledronate 64 aspirin heparin 64 Peginterferon Alfa 2a 64 ALN VSP Phase 64 Quinamed 64 metformin XR 64 aliskiren amlodipine 64 BCR ABL inhibitor 64 APTIVUS 64 Thiarabine 64 raloxifene Evista 64 RANK Ligand inhibitor 64 Triapine 64 angiotensin receptor blocker ARB 64 forodesine 64 xanthine oxidase inhibitor 64 small molecule tyrosine 64 cinacalcet 64 dacarbazine DTIC 64 Chemotherapy Improves 64 Pooled Analysis 64 4mg/kg 64 gastrin analogue TT 64 anthracycline taxane 64 Atripla combines 64 Bortezomib 64 receptor tyrosine kinase inhibitor 64 mg TID 64 pill containing benazepril 64 Relapsing Multiple Sclerosis 64 Recombinant Human 64 peptidic compound 64 DEB# 64 low dose cytarabine 64 gemcitabine Gemzar ® 64 HuLuc# 64 LymphoStat B belimumab 64 Faslodex 64 IMC A# 64 trastuzumab Herceptin ® 64 glycoprotein IIb IIIa inhibitor 64 DUROS 64 Sipuleucel T 64 sapacitabine CYC# 64 Neulasta R 64 Hedgehog Pathway Inhibitor 64 tamoxifen citrate 64 gefitinib Iressa 64 DOXIL 64 recurrent metastatic 64 leukotriene receptor antagonist 64 Platinol 64 Pegylated interferon 64 deforolimus 64 PegIFN RBV 64 Advanced Melanoma 64 chemotherapy fludarabine 64 anastrazole 64 % pramoxine HCl 64 Dasatinib 64 PRT# 64 standard chemotherapy regimens 64 Combination REOLYSIN R 64 Brentuximab Vedotin SGN 64 mycophenolate mofetil 64 fludarabine cyclophosphamide 64 #mg #mg #mg [003] 64 APTIVUS R 64 cisplatin chemotherapy 64 registrational Phase 64 PD LID 64 chemotherapy gemcitabine 64 ALN HPN 64 Phase 2b Trial 64 enzastaurin 64 MEK Inhibitor 64 Newly Diagnosed Multiple Myeloma 64 Epothilone D 64 chemosensitizer 64 Panzem R 64 targeted radiotherapeutic 64 pomalidomide 64 HuMax EGFr 64 INTEGRILIN R 64 humanized interleukin 6 64 histone deacetylase HDAC inhibitor 64 idarubicin 64 Erlotinib 64 NXL# 64 Cisplatin 64 ezetimibe Zetia 64 CIMZIA TM certolizumab pegol 64 JAK2 Inhibitor 64 REMINYL ® 64 metastatic androgen independent 64 irinotecan hydrochloride 64 Fludara 64 alkylating agent 64 Peginterferon alfa 2a 64 HGS ETR2 64 Preclinical Study 64 Refractory Hodgkin Lymphoma 64 brivanib 64 intranasal formulation 64 Improves Survival 64 Doxil 64 EGFr expressing metastatic colorectal 64 Elvitegravir 64 HMG CoA reductase inhibitors 64 Combination therapy 64 TORISEL 64 tiuxetan 63 phenyl salicylate methylene blue 63 investigational immunotherapy 63 bendamustine 63 zoledronic acid Reclast 63 IIIa inhibitor 63 Cytarabine 63 estrogen receptor antagonist 63 lenalidomide dexamethasone 63 Initiated Phase 63 regorafenib 63 #mg/#mg 63 lapatinib Tykerb 63 oral deforolimus 63 3TC lamivudine Epivir 63 recurrent glioblastoma multiforme 63 reslizumab 63 fluoropyrimidine 63 farletuzumab 63 CoFactor 63 Reports Preclinical Data 63 relapsing multiple sclerosis 63 ABVD 63 cisplatin carboplatin 63 metastatic malignant 63 naloxol derivative 63 investigational protease inhibitor 63 evaluating Xcytrin 63 orally inhaled migraine 63 multi kinase inhibitor 63 sunitinib Sutent ® 63 Myelodysplastic Syndrome MDS 63 hormone refractory metastatic prostate 63 pralatrexate injection folate analogue 63 nilotinib Tasigna ® 63 VEGFR2 inhibitor 63 Vaccine Adjuvant 63 Anthracycline 63 CD4 monoclonal antibody 63 sarcoma melanoma 63 interferon ribavirin 63 MetroGel 63 dimeglumine 63 AVOREN 63 metastatic colorectal 63 IAP inhibitor 63 Panzem ® 63 hypertrichosis occurred 63 Tipranavir 63 fallopian tube cancers 63 Orally Active 63 Vinorelbine 63 etoposide 63 intra arterial chemotherapy 63 Provectus Pharmaceuticals specializes 63 Valopicitabine 63 Announces Tentative Approval 63 Initiates Clinical Trial 63 RhuDex TM 63 Thalomid ® 63 azathioprine monotherapy 63 Glatiramer acetate 63 mTOR mammalian target 63 sipuleucel T 63 trabectedin 63 Factor Xa inhibitor 63 Orally administered 63 Deforolimus 63 glatiramer acetate 63 carmustine 63 Bazedoxifene 63 Anti Tumor 63 FOLFOX chemotherapy 63 de novo kidney transplant 63 Bivalirudin 63 irinotecan chemotherapy 63 inhaled corticosteroid ICS 63 drotrecogin alfa activated 63 Randomized Double blind 63 panitumumab Vectibix R 63 unfractionated heparin UFH 63 Dabigatran etexilate 63 Avastin bevacizumab 63 Previously Untreated 63 interferon beta 1a infertility 63 Initiates Phase 63 tenofovir Viread 63 coronary stent merged 63 elotuzumab 63 Aurora Kinase 63 clopidogrel Plavix 63 q8h 63 CHOP chemotherapy 63 ® darbepoetin alfa 63 docetaxel prednisone 63 aflibercept 63 chemotherapeutic regimen 63 gastrointestinal stromal 63 dextromethorphan quinidine 63 Suppository Hydrocortisone Acetate Rectal 63 cyclophosphamide doxorubicin 63 Trastuzumab Herceptin 63 Omacetaxine 63 pyridostigmine 63 meropenem 63 undergoing elective percutaneous 63 5 fluorouracil 63 novel synthetic PEGylated 63 Exforge HCT 63 targeting CD# 63 Nexavar ® 63 relapsed ovarian cancer 63 orally disintegrating 63 interferon alfa 63 INCB# [001] 63 pharmacodynamic profile 63 fluorouracil leucovorin 63 Femara letrozole 63 nucleotide analogue 63 HuMax 63 alpha 2b 63 relapsed multiple myeloma 63 Biogen Genentech 63 CANCIDAS 63 antiangiogenic agent 63 memantine HCl 63 Bendamustine 63 lutropin alfa 63 Phase #b/#a clinical 63 bladder ovarian 63 5 HT2A serotonin 63 Laquinimod 63 histone deacetylase inhibitor 63 Aortic Stenosis 63 demethylating agent 63 pegylated interferons 63 Investigational eFlow Nebulizer System 63 Fingolimod 63 albumin bound paclitaxel 63 Trabectedin 63 antibody trastuzumab 63 FOLFIRI alone 63 Myocet 63 relapsed myeloma 63 entinostat 63 Omnitarg 63 temsirolimus Torisel 63 PNP inhibitor 63 related apoptosis inducing 63 ® bevacizumab 63 Perifosine KRX 63 IMA# 63 PDE4 inhibitor 63 saquinavir ritonavir 63 Node Positive 63 blinded randomized placebo controlled 63 Metastatic Renal Cell Carcinoma 63 epirubicin cisplatin 63 Amgen Neulasta R 63 Adjuvant Therapy 63 DFMO 63 Copegus ® 63 radiation sensitizer 63 Telik logo TELINTRA 63 Cinacalcet 63 epoetin alpha 63 Blinatumomab 63 Immunotherapeutic 63 Ovitrelle R Serostim 63 Levoleucovorin 63 lexidronam injection 63 anti EGFR antibody 63 decitabine 63 alvespimycin 63 Emtriva Viread 63 Tarceva erlotinib 63 IGF 1R inhibitor 63 aflibercept VEGF Trap 63 LymphoStat B TM 63 bupropion SR 63 Posaconazole 63 sulfonylurea metformin 63 IRX 2 63 plus gemcitabine 63 Pruvel TM 63 Factor Receptor 63 KRAS mutations occur 63 Novacort TM 63 Fluticasone 63 essential thrombocythemia ET 63 Tezampanel 63 pegylated IFN 63 known dihydropyrimidine dehydrogenase 63 Castration Resistant Prostate Cancer 63 cyclophosphamide Cytoxan 63 Navelbine 63 Drug Candidate 63 5 HT3 antagonist 63 Vytorin combines 63 tamoxifen Nolvadex ® 63 Targretin 63 sitagliptin Januvia 63 herpetic keratitis 63 Cloretazine 63 PEGylated interferon 63 interferon alfa 2b 63 oral allopurinol 63 Study Shows Promise 63 benzoic acid hyoscyamine sulfate 63 Vildagliptin 63 % hydrocortisone acetate 63 capecitabine Xeloda R 63 alfa 2b 62 metastatic pancreatic 62 chemotherapy docetaxel 62 pegylated interferon alfa 2b 62 Anticancer Activity 62 cis retinoic acid 62 adecatumumab 62 Epratuzumab 62 pioglitazone HCl 62 cholestyramine 62 dacarbazine 62 IXEMPRA 62 Kahalalide F 62 Receives Orphan Drug Designation 62 Janus Kinase 62 Achieves Primary Endpoint 62 Anti Tumor Activity 62 CDK cyclin dependent 62 HSP# inhibitor 62 PegIFN 62 ARB telmisartan 62 Renal Cell Carcinoma 62 mometasone 62 Anti Bacterial Envelope 62 μg dose 62 DG# compounds targeting 62 Budesonide foam crofelemer 62 Piperacillin 62 sitagliptin metformin 62 Tesmilifene 62 ENMD # 62 Gastrointestinal Stromal Tumors 62 gemcitabine Gemzar R 62 DOXIL ® 62 Relapsed Refractory 62 oblimersen 62 Torisel 62 SIMCOR 62 EGFR TKI 62 TRAIL R2 62 COMBIVIR 62 mycophenolic acid 62 ocular formulation 62 hour bronchodilation 62 CYP#A# isoenzyme 62 Ceplene/IL-2 62 Exemestane 62 Teriflunomide 62 luteinizing hormone releasing 62 Pfizer Sutent 62 oral antidiabetic 62 combines bupropion 62 NSABP B 62 TLR9 agonist 62 Adjuvant Chemotherapy 62 hepatic tumors 62 methylnaltrexone bromide 62 anti PlGF 62 Pegasys plus Copegus 62 negative allosteric modulator 62 benazepril 62 Metastatic Melanoma 62 oral Xeloda 62 beclomethasone dipropionate 62 Gamunex C 62 Crestor rosuvastatin 62 immunoconjugate 62 unresectable tumors 62 pyrazinamide 62 LHRH antagonists 62 topical antifungal steroid 62 immunotherapeutic agent 62 desvenlafaxine succinate 62 Nexavar sorafenib tablets 62 Saquinavir 62 Pravachol pravastatin 62 Loceryl ® 62 receptor modulators 62 Successfully Completes Phase 62 Hematological Malignancies 62 ritonavir Norvir 62 rituximab Rituxan 62 miconazole Lauriad ® 62 advanced HER2 positive 62 pegylated interferon alfa 62 M# rationally 62 trastuzumab Herceptin 62 Phase IIb Trial 62 Abiraterone acetate 62 Kidney Transplant Patients 62 hydrocortisone prescription 62 BCG refractory carcinoma 62 imatinib Gleevec ® 62 IMC #B 62 ZACTIMA TM ZD# 62 Eli Lilly Gemzar 62 dihydrochloride Tablets 62 antihormonal 62 basiliximab 62 TYGACIL 62 EOquin TM 62 risedronate Actonel 62 recurrent NSCLC 62 Hycamtin 62 Completes Enrollment 62 saline placebo 62 NU# direct 62 FASLODEX 62 thiazide diuretic 62 small molecule thrombopoietin 62 paclitaxel carboplatin 62 selective phosphodiesterase 62 PEGylated interferon beta 1a 62 adecatumumab MT# 62 pharmacogenomic translational research 62 fosbretabulin 62 cytidine nucleoside analog 62 rifabutin 62 ® DS methenamine 62 beta blocker atenolol 62 oral ridaforolimus 62 aplastic anemia AA 62 uric acid lowering 62 Xcellerated T Cells 62 Iressa gefitinib 62 Benazepril 62 tipranavir 62 postoperative chemotherapy 62 ara C 62 tazobactam 62 Granulocyte Colony Stimulating Factor 62 indinavir Crixivan 62 Sanofi Aventis Taxotere 62 medroxyprogesterone acetate 62 Known generically 62 Ranibizumab 62 trastuzumab DM1 62 vidofludimus 62 thetreatment 62 Glaxo Tykerb 62 Bosentan 62 TRACON Pharmaceuticals 62 pemetrexed Alimta 62 gemtuzumab ozogamicin 62 motexafin gadolinium Injection 62 FIRMAGON 62 fluvastatin Lescol 62 Treatment Reduces 62 Paraplatin 62 PEGASYS ® 62 Boniva ibandronate 62 Previously Treated 62 Dual Opioid 62 axitinib 62 LY# [002] 62 NeuroSTAT ® 62 lamivudine 3TC 62 timolol 62 Demonstrated Significant 62 Seliciclib 62 A1PI 62 doxazosin 62 levoleucovorin 62 including eniluracil ADH 62 randomized controlled Phase 62 Darunavir 62 paclitaxel cisplatin 62 Amrubicin 62 investigational integrase inhibitor 62 #HT# 62 protease inhibitor PI 62 taxane chemotherapy 62 cetuximab Erbitux 62 CTAP# Capsules 62 everolimus tablets 62 Roche Pegasys 62 ONCASPAR 62 lamivudine zidovudine 62 Sutent sunitinib malate 62 advanced hepatocellular carcinoma 62 IFN α 62 Interferon alfa 2b 62 Bayer Nexavar 62 IL# PE#QQR 62 FluCAM 62 Fluconazole 62 Bone Metastases 62 1mg 2mg 62 mg RDEA# 62 active comparator 62 hA# 62 Cremophor 62 multicenter placebo controlled 62 poly ADP ribose polymerase 62 KSP inhibitor 62 tolterodine ER 62 cetuximab Erbitux ® 62 TELINTRA R 62 placebo dexamethasone 62 Rituxan rituximab 62 Safinamide 62 dose melphalan 62 Onyx Pharmaceuticals Announces 62 Interferon beta 62 Cutaneous T 62 mTOR inhibitor 62 LHRH receptor positive 62 Pruvel ™ 62 PEG IFN 62 XL# anticancer compounds 62 Mylan Receives Approval 62 Xyfid TM 62 zonisamide SR 62 Malignant Glioma 62 efavirenz EFV 62 tegafur 62 REYATAZ R 62 EXPAREL TM 62 alfuzosin 62 Seroquel quetiapine fumarate 62 Alocrest 62 recombinant tissue plasminogen 62 topoisomerase II inhibitor 62 Novacort R 62 trandolapril 62 evaluating bavituximab 62 Taxol ® 62 unresectable stage 62 alpha interferons 62 peginterferon alpha 2a 62 NAVISTAR R 62 PEG interferon 62 proteasome inhibitor bortezomib 62 Pharma Merck Serono 62 amifostine 62 RG# ITMN 61 isosorbide dinitrate 61 erlotinib Tarceva 61 ibandronate 61 Anastrozole 61 evaluating mipomersen 61 timolol maleate 61 dose cytarabine 61 intravenous bolus 61 Roche Herceptin 61 bevacizumab Avastin Genentech 61 Atypical Hemolytic Uremic Syndrome